Orion
Tracked across 2 events · 12 articles · First seen May 21, 2026 · Last active Jul 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Orion gains exclusive rights to distribute, market, and sell Shilpa Medicare — Shilpa Biologicals Private Limited's nivolumab biosimilar in Europe, expanding its operations in the hospital segment and strengthening its strategy to provide affordable quality medicines.
Jun 30, 2026 · 6 articles
Tech
Impact: Orion is mentioned as a third-party partner that Tenax Therapeutics relies on, indicating a potential manufacturing or development relationship.
Jul 02, 2026 · 6 articles
90
Orion entered agreement Shilpa Medicare — Shilpa Biologicals Private LimitedOrion, Shilpa Medicare...
80
Orion will make payments Shilpa Medicare — Shilpa Biologicals Private LimitedOrion, Shilpa Medicare...
80
Shilpa Medicare — Shilpa Biologicals Private Limited entered agreement OrionOrion, Shilpa Medicare...
ERGEN INTELLIGENCE
Track Orion live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard